Dr. Joanna Francis continues her series comparing the two GLP-1 drugs. Tap through for her take on how they differ.
Recap by typeshit. Post by @drjoannafrancis on Instagram.
An investing platform's company history runs from Lilly's 1876 founding through Humulin and Prozac to its obesity drug boom. Background, not news.
Generic advice that a lack of hunger doesn't mean you've eaten enough, with a nudge toward smaller portions built around protein.
Dr. Mimi Tan points to a wider set of obesity treatments and notes Ozempic is the semaglutide brand meant for type 2 diabetes.
Brian Underwood shares that the Men's Health fall issue starring Drake Maye is on newsstands, with peptides among the topics inside.
Police arrested a man following a seizure of unlicensed weight loss injections. The Irish News has the details on the arrest and what was found.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
Loading…